Checkpoint Inhibitor Induced Colitis and Arthritis -Immunomodulation With IL-6 Blockade and Exploration of Disease Mechanisms
Clinical trial NCT03601611 · COMPLETED
Trial details
- NCT number
- NCT03601611
- Sponsor
- Herlev Hospital
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-01
- Primary completion
- 2020-01-28
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.